ask="8.79"
ask_size="500"
average_daily_volume="31524"
bid="7.85"
bid_size="200"
book_value="3.34"
change="+0.41"
change_from_200_day_moving_average="1.91"
change_from_50_day_moving_average="1.44"
change_from_52_week_high="-1.29"
change_From_52_week_low="4.98"
change_in_percent="+5.07%"
close="8.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="686000"
high="8.79"
high_52_weeks="9.79"
last_trade_date="2/7/2017"
last_trade_price="8.50"
last_trade_size="200"
last_trade_time="3:51pm"
low="8.09"
low_52_weeks="3.52"
market_capitalization="180.88M"
moving_average_200_day="6.59"
moving_average_50_day="7.06"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.25"
open="8.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+28.94%"
percent_change_from_50_day_moving_average="+20.46%"
percent_change_from_52_week_high="-13.15%"
percent_change_from_52_week_low="+141.48%"
previous_close="8.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.42"
price_per_sales="33.11"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.92"
stock_exchange="NMS"
symbol="NBRV"
volume="42454"
weeks_range_52="3.52 - 9.79"
